Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation.

dc.contributor.authorBişgin, Atıl
dc.contributor.authorBoğa, İbrahim
dc.contributor.authorEskut, Kaan İhsan
dc.contributor.authorRencüzoğulları, Çağla
dc.contributor.authorSönmezler, Özge
dc.contributor.authorKöse, Fatih
dc.contributor.authorBeşen, Ali Ayberk
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorDişel, Umut
dc.contributor.authorKoçer, Nazım Emrah
dc.contributor.authorBolat, Filiz
dc.contributor.authorJinga, Dan-Corneliu
dc.contributor.authorLazar, Ioana
dc.contributor.authorPathak, Surajit
dc.date.accessioned2024-01-11T09:06:52Z
dc.date.available2024-01-11T09:06:52Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipInfoGenom RD Laboratoriesen_US
dc.identifier.citationBişgin, A., Boğa, İ., Eskut, K. İ., Rencüzoğulları, Ç., Sönmezler, Ö., Köse, F. ... Pathak, S. (2023). Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June, 2023.
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12122
dc.identifier.volume41
dc.identifier.wos001053772003977en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCDx Tests Evaluation
dc.subjectReporting Results
dc.subjectHRD Scoring
dc.subjectStatistical Guidance
dc.titleClinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation.
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: